Zentalis Pharmaceuticals | 144:擬議出售證券
Zentalis Pharmaceuticals | 4:持股變動聲明-高管 HAUSMAN DIANA
Zentalis Pharmaceuticals | 10-Q:季度報表
Zentalis Pharmaceuticals | 8-K:Zentalis Pharmicals公佈2024年第一季度財務業績和運營進展
Zentalis Pharmaceuticals | DEFA14A:其他
Zentalis Pharmaceuticals | DEF 14A:股東委託書決議
Zentalis Pharmaceuticals | ARS:年度報告
Zentalis Pharmaceuticals | 3:首次持股聲明-高管 Vultaggio Vincent
Zentalis Pharmaceuticals | 8-K:重大事件
Zentalis Pharmaceuticals | 8-K:重大事件
Zentalis Pharmaceuticals | S-8:員工福利計劃證券登記
Zentalis Pharmaceuticals | S-3ASR:“知名成熟發行人”證券註冊聲明
Zentalis Pharmaceuticals | 10-K:年度報表
Zentalis Pharmaceuticals | 8-K:重大事件
Zentalis Pharmaceuticals | 8-K:重大事件
Zentalis Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Kenneth Griffin(5.3%),Citadel Advisors LLC(5.1%)等
Zentalis Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(7.56%)
Zentalis Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Avidity Partners Management LP(0%),Avidity Partners Management (GP) LLC(0%)等
Zentalis Pharmaceuticals | 144:擬議出售證券
Zentalis Pharmaceuticals | 144:擬議出售證券
暫無數據